Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Propiverine Hydrochloride Extended Release (ER) Compared to Immediate Release (IR) in Patients With Neurogenic Detrusor Overactivity. A Randomized, Double Blind, Parallel Group, Multicenter Clinical Trial

NCT01530620 is registered in ClinicalTrials.gov with APOGEPHA Arzneimittel GmbH as lead sponsor.

NCT NCT01530620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01530620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Propiverine Hydrochloride Extended Release (ER) Compared to Immediate Release (IR) in Patients With Neurogenic Detrusor Overactivity. A Randomized, Double Blind, Parallel Group, Multicenter Clinical Trial
Lead sponsor
APOGEPHA Arzneimittel GmbH
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
July 31, 2006
Enrollment
66 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder disorder, neurogenic, neurogenic bladder disorder, neurogenic urinary bladder disorder, overactive detrusor function, urinary bladder disorder, neurogenic, urinary bladder neurogenic dysfunction, urinary bladder, neurogenic, urinary incontinence, urologic diseases